ACMSD Back

aminocarboxymuconate semialdehyde decarboxylase

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of ACMSD
The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase; EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.[supplied by OMIM, Oct 2004].

Community Annotation of ACMSD Add / Edit ACMSD: Annotations

No community annotations yet for ACMSD.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

ACMSD is highly significantly mutated in
(none)
ACMSD is significantly mutated in
(none)
ACMSD is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for ACMSD